药物-药物共形系统:对于水溶性较差的药物,一种新兴的配方策略
Hongge Wang1, Peixu Zhao1, Ruilong Ma1
1Wuya College of Innovation, Shenyang Pharmaceutical University, No. 103, Wenhua Road, Shenyang 110016, China.
Drug discovery today
|January 14, 2024
概括
药物-药物共形系统提高了药物开发的可溶性和稳定性. 这些系统提供了更好的物理稳定性,并为各种临床需求提供了组合疗法.
科学领域:
- 制药科学 制药科学
- 材料科学 材料科学 材料科学
- 药物运输 药物运输 药物运输
背景情况:
- 小分子药物的水溶性差阻碍了临床药物开发.
- 无形化提高了药物的溶解性,但无形形式缺乏热力学稳定性.
- 药物-药物共形系统提供了增强的溶解和物理稳定性.
研究的目的:
- 审查制造和特征化药物-药物共形系统的进展.
- 为了总结最近的药物-药物共形系统的应用.
- 提供对共形药物开发的未来视角.
主要方法:
- 对制造技术 (例如喷雾干燥,热挤出) 的文献综述.
- 分析表征方法 (例如,X射线衍射,微分扫描热度计).
- 汇编报告的药物-药物共形系统及其应用.
主要成果:
- 同形态系统表现出改善的水溶性和溶解率.
- 在共形配方中增强无形药物的物理稳定性.
- 在各种疾病的联合治疗中成功应用.
结论:
- 药物-药物共形系统是改善药物的溶解性和稳定性的有希望的策略.
- 这些系统促进组合疗法,解决未满足的临床需求.
- 进一步研究制造优化和临床翻译是有必要的.
相关概念视频
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
310
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
310
Factors Influencing Drug Absorption: Pharmaceutical Parameters
134
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
134
Factors Influencing Drug Absorption: Physicochemical Parameters
278
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
278
Factors Affecting Dissolution: Particle Size and Effective Surface Area
850
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
850
Factors Influencing Drug Absorption: Drug Dissolution
508
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
508
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
208
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
208


